This company listing is no longer active
Satsuma Pharmaceuticals 관리
관리 기준 확인 2/4
Satsuma Pharmaceuticals' CEO is John Kollins, appointed in Jul 2016, he has a tenure of 6.92 years. His total yearly compensation is $1.91M , comprised of 27.8% salary and 72.2% bonuses, including company stock and options. He directly owns 0.94% of the company’s shares, worth €317.23K. The average tenure of the management team and the board of directors is 5.9 years and 5.8 years respectively.
주요 정보
John Kollins
최고 경영자
US$1.9m
총 보상
CEO 급여 비율 | 27.8% |
CEO 임기 | 6.9yrs |
CEO 소유권 | 0.9% |
경영진 평균 재임 기간 | 5.9yrs |
이사회 평균 재임 기간 | 5.8yrs |
최근 관리 업데이트
Recent updates
CEO 보상 분석
날짜 | 총 보상 | 급여 | 회사 수익 |
---|---|---|---|
Mar 31 2023 | n/a | n/a | -US$65m |
Dec 31 2022 | US$2m | US$530k | -US$70m |
Sep 30 2022 | n/a | n/a | -US$62m |
Jun 30 2022 | n/a | n/a | -US$61m |
Mar 31 2022 | n/a | n/a | -US$56m |
Dec 31 2021 | US$830k | US$500k | -US$51m |
Sep 30 2021 | n/a | n/a | -US$48m |
Jun 30 2021 | n/a | n/a | -US$47m |
Mar 31 2021 | n/a | n/a | -US$46m |
Dec 31 2020 | US$4m | US$456k | -US$48m |
Sep 30 2020 | n/a | n/a | -US$46m |
Jun 30 2020 | n/a | n/a | -US$42m |
Mar 31 2020 | n/a | n/a | -US$37m |
Dec 31 2019 | US$1m | US$391k | -US$28m |
Sep 30 2019 | n/a | n/a | -US$20m |
Jun 30 2019 | n/a | n/a | -US$13m |
Mar 31 2019 | n/a | n/a | -US$8m |
Dec 31 2018 | US$568k | US$362k | -US$7m |
보상 대 시장: John's total compensation ($USD1.91M) is above average for companies of similar size in the German market ($USD407.72K).
보상과 수익: John's compensation has increased whilst the company is unprofitable.
CEO
John Kollins (60 yo)
6.9yrs
테뉴어
US$1,909,812
보상
Mr. John A. Kollins, MBA, has been Director, President and Chief Executive Officer of Satsuma Pharmaceuticals, Inc since July 2016. He served as Chief Business Officer and Senior Vice President of Transcep...
리더십 팀
이름 | 위치 | 테뉴어 | 보상 | 소유권 |
---|---|---|---|---|
President | 6.9yrs | US$1.91m | 0.94% € 317.2k | |
Chief Financial Officer | 4.4yrs | US$936.85k | 0.042% € 14.2k | |
VP & Head of Operations | 6.4yrs | 데이터 없음 | 데이터 없음 | |
Senior VP & Head of Chemistry | 5.9yrs | 데이터 없음 | 데이터 없음 | |
VP & Head of Regulatory Affairs | 5.1yrs | 데이터 없음 | 데이터 없음 |
5.9yrs
평균 재임 기간
58yo
평균 연령
경험이 풍부한 관리: 1LV's management team is seasoned and experienced (5.9 years average tenure).
이사회 구성원
이름 | 위치 | 테뉴어 | 보상 | 소유권 |
---|---|---|---|---|
President | 6.9yrs | US$1.91m | 0.94% € 317.2k | |
Independent Director | 2.9yrs | US$132.08k | 0% € 0 | |
Independent Director | 5.8yrs | US$131.58k | 0% € 0 | |
Independent Chairman of the Board | 6.5yrs | US$160.08k | 0% € 0 | |
Independent Director | 6.5yrs | US$120.58k | 0% € 0 | |
Independent Director | 1.7yrs | US$124.58k | 0% € 0 | |
Independent Director | 7yrs | US$124.08k | 0% € 0 | |
Independent Director | 4.1yrs | US$132.08k | 0% € 0 | |
Independent Director | 5.7yrs | US$126.08k | 0% € 0 |
5.8yrs
평균 재임 기간
59yo
평균 연령
경험이 풍부한 이사회: 1LV's board of directors are considered experienced (5.8 years average tenure).